CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2021; 08(03): 203-207
DOI: 10.1055/s-0041-1735653
Brief Report

Anticoagulation after Spontaneous Intraparenchymal Hemorrhage in Patients with Mechanical Heart Valves and Concomitant Atrial Fibrillation

Jennifer H. Kang
1   Department of Neurology, Duke University Medical Center, Durham, North Carolina, United States
,
Michael L. James
1   Department of Neurology, Duke University Medical Center, Durham, North Carolina, United States
2   Department of Anesthesiology, Duke University, Durham, North Carolina, United States
,
Allison Gibson
1   Department of Neurology, Duke University Medical Center, Durham, North Carolina, United States
,
Ovais Inamullah
1   Department of Neurology, Duke University Medical Center, Durham, North Carolina, United States
,
Gary Clay Sherrill
3   The University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States
,
Michael W. Lutz
1   Department of Neurology, Duke University Medical Center, Durham, North Carolina, United States
,
Christa B. Swisher
1   Department of Neurology, Duke University Medical Center, Durham, North Carolina, United States
› Author Affiliations

Abstract

Aim Patients with mechanical heart valves and coexisting atrial fibrillation (AFib-MHV) who suffer an intraparenchymal hemorrhage (IPH, defined as bleeding solely within the brain parenchyma and/or ventricle) are at a high risk of thromboembolism without anticoagulation. Data are lacking regarding the safety of early re-initiation of anticoagulation in these patients.

Patients and Methods We performed a descriptive, single-institution retrospective analysis of patients with AFib-MHV who suffered a non-traumatic, supratentorial IPH between July 2013 and June 2017. We analyzed the patients and IPH characteristics, anticoagulation and antiplatelet use, the occurrence of thrombotic and hemorrhage complications, and discharge disposition. We described the timing of initiation of anticoagulation and outcomes after IPH while in-patient.

Results Six patients with AFib-MHV suffered a spontaneous IPH. Four were initiated on anticoagulation prior to discharge, of whom two were initiated within 3 days post-hemorrhage. These patients suffered no bleeding complications and were discharged home with a modified Rankin Scale of 1.

Conclusion Patients with AFib-MHV who suffer a spontaneous IPH are a rare population to study. Further studies to guide the management of restarting anticoagulation in this select population are warranted.



Publication History

Article published online:
24 October 2021

© 2021. Indian Society of Neuroanaesthesiology and Critical Care. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India